CTRI/2017/06/008783招募中未知
Comparison of 4 weeks versus 12 weeks Anti-convulsant therapy for Acute Symptomatic Seizure in Children with Acute Encephalitis syndrome- An Open Label, Randomized Controlled Trial
Post Graduate Institute of Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children with acute encephalitis syndrome with acute symptomatic seizures on single anti-epileptic drug will be enrolled in Out patient clinic at 4 week of illness
排除标准
- •1.Children with chronic meningitis, brain abscess, intracranial Space occupying lesion
- •2.Children with prior history of seizures, prior focal neurological deficit or abnormal development prior to development of seizures
- •3.HIV, Chronic Liver disease, Chronic Kidney disease, acute hepatic encephalopathy
- •4.Children on two or more than 2 anti-epileptic drug, severely affected children (Pediatric Cerebral Performance Category Scale (PCPC) Score, Pediatric Overall Performance Category Scale with category score of 5)
- •5.Refusal of consent
研究者
相似试验
尚未招募
不适用
Efficacy and safety of four-weeks versus twelve-weeks loading doses spacing of intravitreal Aflibercept for treatment of macular edema associated with Central Retinal Vein OcclusioEye DiseasesPACTR202201655513401Egypt health insurance60
已完成
不适用
Comparison of the effectiveness between 4 weeks and 8 weeks treatment of lansoprazole in iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissectioDiseases of the digestive systemKCT0000488Chung-Ang Univerisity Hospital74
Unknown
不适用
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis SyndromeSeizuresNCT03181945Post Graduate Institute of Medical Education and Research, Chandigarh60
进行中（未招募）
1 期
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trialThe Active substance of Osteopor is Ossein Hydroxyapatite.Treatment of processes characterized by decalcification: osteoporosis, Cushing syndrome, thyrotoxicosis.MedDRA version: 9.1Level: LLTClassification code 10006956Term: Calcium deficiencyEUCTR2008-002280-14-FRPierre Fabre Médicament58
招募中
不适用
Comparison of the effect of 4 weeks of cuping and kinesiotype in patients with carpal tunnel syndrome during pregnancyIRCT20151128025265N3Shahid Beheshti University of Medical Sciences30